| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.8M | -19.7% | -16.4% |
| Cost of Revenue | $1.6M | +5.1% | -17.2% |
| Gross Profit | $5.2M | -25.1% | -16.1% |
| R&D Expense | $5.3M | -15.2% | +0.0% |
| SG&A Expense | $6.0M | -25.4% | -22.2% |
| Operating Income | -$14.1M | +0.5% | -0.7% |
| Pre-tax Income | -$12.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $13.0M | -14.8% | -64.9% |
| Short-term Investments | $92.8M | -16.7% | -20.6% |
| Accounts Receivable | $8.3M | +44.4% | +82.1% |
| Inventory | $7.6M | -4.1% | -26.8% |
| Current Assets | $124.6M | -13.0% | -27.9% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$31.7M | — | — |
| Capital Expenditures | $1.5M | — | — |
| Investing Cash Flow | $16.3M | — | — |
| Financing Cash Flow | $551K | — | — |
| Free Cash Flow | -$33.3M | — | — |
| -0.5% |
| -7.4% |
| Net Income | -$12.4M | -0.5% | -7.4% |
| EPS (Basic) | -$0.12 | +0.0% | -9.1% |
| EPS (Diluted) | -$0.12 | +0.0% | -9.1% |
| $213.5M |
| -2.9% |
| -14.1% |
| Current Liabilities | $16.1M | +39.4% | -8.6% |
| Total Liabilities | $33.2M | +14.4% | -6.0% |
| Stockholders' Equity | $180.3M | -5.5% | -15.5% |